Summit Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US86627T1088
USD
16.49
-0.88 (-5.07%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summarySummit Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-5.07%
0.03%
1W
-3.23%
-0.35%
1M
-9%
0.08%
YTD
-5.72%
1.02%
1Y
-33.1%
13.02%
3Y
269.73%
72.04%
5Y
194.99%
80.03%
10Y
194.99%
262.66%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.05%
0%
-12.05%
6 Months
-41.13%
0%
-41.13%
1 Year
-33.1%
0%
-33.1%
2 Years
303.18%
0%
303.18%
3 Years
269.73%
0%
269.73%
4 Years
700.49%
0%
700.49%
5 Years
194.99%
0%
194.99%

Summit Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary